Selected article for: "cc NC ND International license and logistic regression"
Author: Jun Fei; Lin Fu; Ying Li; Hui-Xian Xiang; Ying Xiang; Meng-Die Li; Fang-Fang Liu; De-xiang Xu; Hui Zhao
Title: Reduction of lymphocyte at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study
  • Document date: 2020_4_6
    • ID: 8q1veo3q_36
    Snippet: Of interest, lymphocyte percentage was reduced only in COVID-19 patients with either cardiac diseases or pulmonary chronic diseases. To control possible confounding factors, multivariable logistic regression was used to further analyze the influence of gender, age and comorbidities on lymphocyte reduction in COVID-19 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display th.....
    Document: Of interest, lymphocyte percentage was reduced only in COVID-19 patients with either cardiac diseases or pulmonary chronic diseases. To control possible confounding factors, multivariable logistic regression was used to further analyze the influence of gender, age and comorbidities on lymphocyte reduction in COVID-19 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cardiac disease and chronic disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiac disease and International license: 1, 2, 3
    • cardiac disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiac disease and lymphocyte percentage: 1
    • cardiac disease and lymphocyte reduction: 1, 2
    • cardiac disease and multivariable logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cardiac disease and pulmonary chronic disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiac disease and pulmonary chronic disease cardiac disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cc NC ND International license and chronic disease: 1, 2, 3, 4, 5, 6, 7
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cc NC ND International license and lymphocyte percentage: 1
    • cc NC ND International license and lymphocyte reduction: 1, 2, 3, 4, 5
    • cc NC ND International license and multivariable logistic regression: 1, 2, 3
    • cc NC ND International license and pulmonary chronic disease: 1, 2, 3, 4, 5
    • chronic disease and International license: 1, 2, 3, 4, 5, 6, 7, 8
    • chronic disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic disease and lymphocyte percentage: 1, 2, 3, 4
    • chronic disease and lymphocyte reduction: 1, 2